Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTDSP2 antisense RNA 1 (CTDSP2-AS1)
- Target
- CTDSP2-AS1
- Molecular classification
- Long non-coding RNA, Antisense RNA, Non-coding RNA
01
Overview
CTDSP2 antisense RNA 1 (CTDSP2-AS1) is a long non-coding RNA gene transcribed on the strand opposite to the CTD Small Phosphatase 2 (CTDSP2) gene. Like other antisense lncRNAs, CTDSP2-AS1 may regulate the expression of its sense counterpart gene and/or participate in broader chromatin- and epigenetic-based gene silencing or activation, potentially influencing cellular pathways such as cell proliferation, apoptosis, or differentiation. Its precise biological functions and clinical relevance remain insufficiently characterized. Similar antisense RNAs are increasingly recognized for their roles in gene regulation, cancer biology, and as potential diagnostic or prognostic biomarkers, yet CTDSP2-AS1 itself is not a validated disease biomarker or therapeutic target.
02
Biological functions
Epigenetic regulationGene expression modulationPotential regulation of CTDSP2 (by antisense overlap, inferred from general antisense lncRNA mechanisms)
03
Disease associations
Potential involvement in cancerPotential involvement in developmental disorders
04
Biomarkers
Antisense RNAs, in general, are being explored as biomarkers for diagnosis or prognosis in cancer and other diseases
Beyond the preview
Go deeper on CTDSP2 antisense RNA 1 (CTDSP2-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CTDSP2 antisense RNA 1 (CTDSP2-AS1).